Idarucizumab for a traumatic head injury patient taking dabigatran
ConclusionWe managed a patient taking dabigatran who suffered traumatic intracranial hemorrhage by administering idarucizumab preoperatively without the need for blood transfusion perioperatively. We suggest that idarucizumab could be a potent therapeutic bridge to definitive surgical management in such patients with traumatic brain injury who are taking dabigatran.
Source: International Journal of Emergency Medicine - Category: Emergency Medicine Source Type: research
More News: Accidents | Bleeding | Blood Transusion | Brain | Craniotomy | CT Scan | Emergency Medicine | Head Injury | Hemorrhagic Stroke | Hydrocephalus | Japan Health | Neurology | Pradaxa | Rehabilitation